Literature DB >> 33270534

Developmental origins of metabolic diseases.

Daniel J Hoffman1, Theresa L Powell2, Emily S Barrett3, Daniel B Hardy3.   

Abstract

Almost 2 billion adults in the world are overweight, and more than half of them are classified as obese, while nearly one-third of children globally experience poor growth and development. Given the vast amount of knowledge that has been gleaned from decades of research on growth and development, a number of questions remain as to why the world is now in the midst of a global epidemic of obesity accompanied by the "double burden of malnutrition," where overweight coexists with underweight and micronutrient deficiencies. This challenge to the human condition can be attributed to nutritional and environmental exposures during pregnancy that may program a fetus to have a higher risk of chronic diseases in adulthood. To explore this concept, frequently called the developmental origins of health and disease (DOHaD), this review considers a host of factors and physiological mechanisms that drive a fetus or child toward a higher risk of obesity, fatty liver disease, hypertension, and/or type 2 diabetes (T2D). To that end, this review explores the epidemiology of DOHaD with discussions focused on adaptations to human energetics, placental development, dysmetabolism, and key environmental exposures that act to promote chronic diseases in adulthood. These areas are complementary and additive in understanding how providing the best conditions for optimal growth can create the best possible conditions for lifelong health. Moreover, understanding both physiological as well as epigenetic and molecular mechanisms for DOHaD is vital to most fully address the global issues of obesity and other chronic diseases.

Entities:  

Keywords:  developmental origins; environmental toxins; metabolic diseases; obesity; placenta

Mesh:

Year:  2020        PMID: 33270534      PMCID: PMC8526339          DOI: 10.1152/physrev.00002.2020

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   46.500


  555 in total

Review 1.  Genomic imprinting, growth and maternal-fetal interactions.

Authors:  Féaron C Cassidy; Marika Charalambous
Journal:  J Exp Biol       Date:  2018-03-07       Impact factor: 3.312

2.  The fetal and childhood growth of persons who develop type 2 diabetes.

Authors:  T Forsén; J Eriksson; J Tuomilehto; A Reunanen; C Osmond; D Barker
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

3.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

4.  Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Authors:  Karen K Mestan; Nina Gotteiner; Nicolas Porta; William Grobman; Emily J Su; Linda M Ernst
Journal:  J Pediatr       Date:  2017-02-02       Impact factor: 4.406

5.  Agonistic and antagonistic effects of phthalates and their urinary metabolites on the steroid hormone receptors ERα, ERβ, and AR.

Authors:  Anika Engel; Thorsten Buhrke; Francine Imber; Sönke Jessel; Albrecht Seidel; Wolfgang Völkel; Alfonso Lampen
Journal:  Toxicol Lett       Date:  2017-05-29       Impact factor: 4.372

6.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

7.  The association between PFOA, PFOS and serum lipid levels in adolescents.

Authors:  Sarah Dee Geiger; Jie Xiao; Alan Ducatman; Stephanie Frisbee; Kim Innes; Anoop Shankar
Journal:  Chemosphere       Date:  2013-11-13       Impact factor: 7.086

8.  A novel rat model of gestational diabetes induced by intrauterine programming is associated with alterations in placental signaling and fetal overgrowth.

Authors:  Evangelina Capobianco; Daiana Fornes; Ivana Linenberg; Theresa L Powell; Thomas Jansson; Alicia Jawerbaum
Journal:  Mol Cell Endocrinol       Date:  2015-12-30       Impact factor: 4.102

9.  Increased hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance.

Authors:  Robert H Lane; Nicole K MacLennan; Jennifer L Hsu; Sara M Janke; Tho D Pham
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

10.  Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice.

Authors:  Thiago M Batista; Paloma Alonso-Magdalena; Elaine Vieira; Maria Esmeria C Amaral; Christopher R Cederroth; Serge Nef; Ivan Quesada; Everardo M Carneiro; Angel Nadal
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

View more
  18 in total

1.  Intestinal epithelial c-Maf expression determines enterocyte differentiation and nutrient uptake in mice.

Authors:  Catalina Cosovanu; Philipp Resch; Stefan Jordan; Andrea Lehmann; Markus Ralser; Vadim Farztdinov; Joachim Spranger; Michael Mülleder; Sebastian Brachs; Christian Neumann
Journal:  J Exp Med       Date:  2022-09-19       Impact factor: 17.579

2.  Birth weight and maternal energy status during pregnancy as predictors of epigenetic age acceleration in young adults from metropolitan Cebu, Philippines.

Authors:  Christopher W Kuzawa; Calen P Ryan; Linda S Adair; Nanette R Lee; Delia B Carba; Julia L MacIsaac; Kristy Dever; Parmida Atashzay; Michael S Kobor; Thomas W McDade
Journal:  Epigenetics       Date:  2022-05-14       Impact factor: 4.861

3.  Dietary protein intake during pregnancy and birth weight among Chinese pregnant women with low intake of protein.

Authors:  Jiaomei Yang; Qianqian Chang; Xueye Tian; Binyan Zhang; Lingxia Zeng; Hong Yan; Shaonong Dang; Yue-Hua Li
Journal:  Nutr Metab (Lond)       Date:  2022-07-05       Impact factor: 4.654

Review 4.  Are Brain and Cognitive Reserve Shaped by Early Life Circumstances?

Authors:  Susanne R de Rooij
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

Review 5.  Parental overnutrition by carbohydrates in developmental origins of metabolic syndrome.

Authors:  O Šeda
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

6.  Nobiletin Inhibits Hypoxia-Induced Placental Damage via Modulating P53 Signaling Pathway.

Authors:  Meng-Ling Zhang; Qian Yang; Yan-Di Zhu; Ya-Di Zhang; Rui Zhang; Jian Liu; Xiao-Yan Zhao; Qin-Yu Dang; Dong-Xu Huang; Ming-Yuan Zhang; Yu-Chen Wei; Zhuo Hu; Xia-Xia Cai; Li-Fang Gao; Yang Shan; Huan-Ling Yu
Journal:  Nutrients       Date:  2022-06-01       Impact factor: 6.706

7.  PHYSIOLOGICAL REVIEWS: THE PAST, THE PRESENT, AND THE FUTURE.

Authors:  Sadis Matalon; Carol Ann Remme; Willis K Samson
Journal:  Physiol Rev       Date:  2021-01-14       Impact factor: 37.312

8.  Cohort profile: Understanding Pregnancy Signals and Infant Development (UPSIDE): a pregnancy cohort study on prenatal exposure mechanisms for child health.

Authors:  Thomas O'Connor; Meghan Best; Jessica Brunner; Allison Avrich Ciesla; Allison Cunning; Ntemena Kapula; Amber Kautz; Leena Khoury; Allison Macomber; Ying Meng; Richard K Miller; Hannah Murphy; Carolyn M Salafia; Ana Vallejo Sefair; Jishyra Serrano; Emily Barrett
Journal:  BMJ Open       Date:  2021-04-01       Impact factor: 2.692

Review 9.  Deep Eutectic Solvents as Active Pharmaceutical Ingredient Delivery Systems in the Treatment of Metabolic Related Diseases.

Authors:  Cixin Huang; Xiunian Chen; Chao Wei; Hongwei Wang; Hua Gao
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

10.  Editorial: Developmental Programming of Metabolic Diseases.

Authors:  Sarah J Glastras; Damaskini Valvi; Amita Bansal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.